Mirae Asset Global Investments Co. Ltd. Purchases Shares of 14,490 VanEck Pharmaceutical ETF (NASDAQ:PPH)
Mirae Asset Global Investments Co. Ltd. acquired a new position in VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) during the first quarter, according to its most recent filing with the SEC. The firm acquired 14,490 shares of the company’s stock, valued at approximately $1,314,000. Mirae Asset Global Investments Co. Ltd. owned about 0.25% of VanEck Pharmaceutical ETF as of its most recent filing with the SEC.
Other hedge funds have also recently made changes to their positions in the company. Raymond James Financial Services Advisors Inc. raised its stake in VanEck Pharmaceutical ETF by 462.4% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 18,148 shares of the company’s stock worth $1,477,000 after buying an additional 14,921 shares in the last quarter. International Assets Investment Management LLC lifted its stake in shares of VanEck Pharmaceutical ETF by 910.0% in the 4th quarter. International Assets Investment Management LLC now owns 27,502 shares of the company’s stock valued at $2,238,000 after purchasing an additional 24,779 shares during the period. Allworth Financial LP bought a new stake in shares of VanEck Pharmaceutical ETF during the fourth quarter valued at approximately $28,000. Investment Partners Asset Management Inc. purchased a new stake in VanEck Pharmaceutical ETF in the fourth quarter worth $354,000. Finally, Private Client Services LLC bought a new position in VanEck Pharmaceutical ETF in the fourth quarter worth $298,000.
VanEck Pharmaceutical ETF Trading Down 0.6 %
Shares of PPH stock opened at $92.98 on Tuesday. The company’s fifty day moving average price is $91.10 and its 200-day moving average price is $88.63. The stock has a market cap of $626.69 million, a PE ratio of 21.04 and a beta of 0.72. VanEck Pharmaceutical ETF has a 12 month low of $74.05 and a 12 month high of $93.84.
VanEck Pharmaceutical ETF Cuts Dividend
The firm also recently announced a dividend, which was paid on Friday, July 5th. Shareholders of record on Monday, July 1st were paid a dividend of $0.3558 per share. The ex-dividend date of this dividend was Monday, July 1st.
VanEck Pharmaceutical ETF Company Profile
The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.
Recommended Stories
Receive News & Ratings for VanEck Pharmaceutical ETF Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for VanEck Pharmaceutical ETF and related companies with MarketBeat.com’s FREE daily email newsletter.
